NSEDisclosure under SEBI Takeover Regulations1 Jul 2026 · 1 Jul 2026, 12:46 pm
Disclosure under SEBI Takeover Regulations
Aarey Drugs & Pharmaceuticals Limited · AAREYDRUGS
✦ AI SummaryRegulatory
Aarey Drugs & Pharmaceuticals Limited has submitted a disclosure under SEBI Takeover Regulations, as per Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Nimit Rajesh Ghatalia has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.